Browse > Article

Severe Pneumonia Caused by 2009 Pandemic Influenza A (H1N1) Virus in Children and Corticosteroid Treatment  

Sohn, Yu Rak (Department of Pediatrics, Daegu Fatima Hospital)
Kim, Jong Hee (Department of Pediatrics, Daegu Fatima Hospital)
Ma, Sang Hyuk (Department of Pediatrics, Changwon Fatima Hospital)
Lee, Kyung Yil (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Kang, Jin Han (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Publication Information
Pediatric Infection and Vaccine / v.18, no.2, 2011 , pp. 193-200 More about this Journal
Abstract
Purpose : The effect of corticosteroid on severe pneumonia caused by 2009 pandemic influenza (H1N1) A virus is controversial. This study was aimed to present the effects of early, short-term corticosteroid treatment for severe pneumonia with this virus infection. Methods : A retrospective analysis was performed on severe pneumonia patients (37 patients) who had severe respiratory distress at presentation requiring oxygen therapy and received intravenous methylprednisolone (MP, 8-10 mg/kg, divided in 4 doses/day for 2-3 days) with oseltamivir. The clinical and laboratory characteristics of the patients were evaluated through the medical records and chest radiographic findings. Results : The mean age and male-to-female ratio of the patients were 6.5${\pm}$2.9 years of age, and 3.4:1 (male 29 patients), respectively. The 5-9 aged group was predominant among the age groups (25 patients, 67.6%). Duration of fever prior to admission was 1.4${\pm}$0.6 days and dyspnea developed within 24 h after beginning of respiratory symptoms in all patients. All patients were previously healthy and received oseltamivir within 48 h. Thirteen patients (35.1%) developed dyspnea during oseltamivir treatment. Following MP infusion, all 37 patients including 13 progressive pneumonia patients during oseltamivir treatment showed an immediate halt in the progression of pneumonic infiltration with rapid clinical improvement. There were no side-effects following steroid use. Conclusion : For severe pneumonia patients, early corticosteroid treatment halted clinical exacerbation, and possibly prevented progression to acute respiratory distress syndrome. Further controlled clinical studies are needed for the role of corticosteroids and antivirals on severely affected patients with influenza virus infections.
Keywords
H1N1 influenza virus; Corticosteroid; Pneumonia; Children;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459:931-9.   DOI   ScienceOn
2 Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15.   DOI   ScienceOn
3 World Health Organization [homepage on the Internet]. Geneva, Switzerland: WHO c2009 [updated 2009 June 11 cited 2009 July 17]. Global Alert and Response; [about 2 screens]. Available from: http://www.who.int/csr/diseea/swineflu/frequently_asked_questions/levels_pandemic_alert/en/index.html
4 Kim WJ. Novel influenza A/H1N1 pandemic: current status and prospects J Korean Med Assoc 2009;52:787-94.   DOI
5 Korean Center for Disease Control. Epidemiology of early detected Novel Influenza A (H1N1) in Korea, 2009. Public Health Wkly Rep 2009;2:689-91.
6 Lee HJ, Min SJ, Choi JW, Kang EK. Clinical characteristics of hospitalized pediatric patients with 2009 novel influenza A infection. Pediatr Allergy Respir Dis 2010;30:130-7.
7 Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza, Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-19.   DOI   ScienceOn
8 Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Intern J Antimicrob Agents 2010;35:421-30.   DOI   ScienceOn
9 Reddy D. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. J Antimicrob Chemother 2010 Apr;65(Suppl 2):ii35-ii40.
10 de Jong MD, Simmons CP, Thanh TT, Hien VH, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-7.   DOI   ScienceOn
11 Eichelberger MC. The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol 2007;20:243-9.   DOI   ScienceOn
12 La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of self-reservation: immunopathology in influenza virus infection. Immunol Cell Biology 2007;85:85-92.   DOI   ScienceOn
13 To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010;50:850-9.   DOI   ScienceOn
14 Lee KY, Rhim JW, Kang JH. Hyperimmune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases. Med Hypotheses 2011;76:64-9.   DOI   ScienceOn
15 Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med 2010;36:33-41.   DOI   ScienceOn
16 Kil HR, Lee JH, Lee KY, Rhim JW, Youn YS, Kang JH. Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus. Critical Care 2011;15:413.   DOI
17 Linko R, Pettila V, Ruokonen E, Varpula T, Sari Karlsson S, Tenhunen J, et al. FINN H1N1-study group. Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A (H1N1) infection in Finland. Acta Anesth Scand (In press).
18 Confalonieri M, Cifaldi R, Dreas L, Viviani M, Biolo M, Gabrielli M. Methylprednisolone infusion for lifethreatening H1N1-virus infection. Ther Adv Respir Dis 2010;4:233-7.   DOI   ScienceOn
19 Roberts C, Nirmalan M, O'Shea S. Steroid-sensitive post-viral inflammatory pneumonitis (PVIP). Am J Respir Crit Care Med 2010;182:1089-90.
20 Annane D. Pro: The illegitimate crusade against corticosteroids for severe H1N1 pneumonia. Am J Respir Crit Care Med 2011;183:1125-6.   DOI   ScienceOn
21 Rhim JW, Lee KY, Youn YS, Kang JH, Kim JC. Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: An observational cohort study. BMC infect Dis 2011;11:225.   DOI   ScienceOn
22 Bettinger JA, Sauve LJ, Scheifele DW, Moore D, Vaudry W, Tran D, et al. Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine 2010;28:3180-4.   DOI   ScienceOn
23 Matthay MA, Lia KD. Con: Corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia. Am J Respir Crit Care Med 2011;183:1127-8.   DOI   ScienceOn
24 Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 2011;183:1207-14.   DOI   ScienceOn
25 Aviram G, Bar-Shai A, Sosna J, Rogowski O, Rosen G, Weinstein I, et al. H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology 2010;255:252-9.   DOI   ScienceOn
26 Brun-Buisson C, Richard JC, Mercat A, Thiebaut A, Brochard L. Early corticosteroids in severe Influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011;183:1200-6.   DOI   ScienceOn
27 Witkop CT, Duffy MR, Macias EA, Gibbons TF, Escobar JD, Burwell KN, et al. Novel influenza A (H1N1) outbreak at the US Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med 2010;38:121-6.   DOI   ScienceOn
28 Confalonieri M, D'Agaro P, Campello C. Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. Intensive Care Med 2010;36:1780-1.   DOI   ScienceOn
29 Choi SH, Kang EY, Kim JS, Kim YK. Radiologic review of an outbreak of the pandemic (H1N1) 2009 Virus Infection at a university hospital in Seoul, Korea. J Korean Soc Radiol 2011;64:341-50.   DOI
30 Korppi M, Don M, Valent F, Calciani M. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Pediatr 2008;97:943-7.   DOI   ScienceOn
31 World Health Organization: Human infection with new influenza A (H1N1) virus: Clinical observations from a school associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009;84:237-48.
32 Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.   DOI   ScienceOn
33 Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systemic review and meta-analysis. Crit Care Med 2009;37:1594-603.   DOI   ScienceOn